As a component of p53-dependent lncRNA (long non-coding RNA), PANDAR (the promoter
of CDKN1A antisense DNA damage activated RNA) participates in the epigenetic regulation …

It has been reported that lncRNA PANDAR (promoter of CDKN1A antisense DNA damage-
activated RNA) is induced as a result of DNA damage, and it regulates the reparation of …

Long non-coding RNAs (lncRNAs), non-protein-coding RNAs that are more than 200
nucleotides in length, have been demonstrated to play a vital role in the pathophysiology of …

Background: A long noncoding RNA, p21-associated ncRNA DNA damage-activated
(PANDA), associates with nuclear transcription factor Y subunit alpha (NF-YA) and inhibits …

Emerging evidence indicates that lncRNAs play important roles in cancer tumourigenesis
and could be used as potential diagnostic biomarkers or therapeutic targets. However, the …

OBJECTIVE: To investigate the expression level of long non-coding RNA promoter of
CDKN1A antisense DNA damage activated RNA (lncRNA PANDAR) in cervical cancer and …

Abstract Background Long non-coding RNAs (lncRNAs) have emerged as biomarkers and
important regulators of tumor development and progression. PANDAR (promoter of …

Long non-coding RNAs (lncRNAs) are emerging as biomarkers and as important regulators
in biological processes and tumorigenesis in cancer. PANDAR (promoter of CDKN1A …

Long noncoding RNAs (lncRNAs) consist of 200 nucleotide sequences that play essential
roles in different processes, including cell proliferation, and differentiation. There is evidence …

Recently, a novel class of transcripts, long noncoding RNAs (lncRNAs), is involved in
diseases including cancer. Here, we investigated the the role of lncRNA PANDAR in the …